HIRSCHMAN ORIN 13D/13G Filings for Acer Therapeutics Inc. (ACER)

HIRSCHMAN ORIN 13D and 13G filings for Acer Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-03-17
4:06 pm
Sale		 2021-03-15 13G Acer Therapeutics Inc.
ACER		 HIRSCHMAN ORIN 0
0.000%		 -982,446decrease
(Position Closed)		 Filing
2021-02-10
4:13 pm
Purchase		 2020-12-31 13G Acer Therapeutics Inc.
ACER		 HIRSCHMAN ORIN 982,446
11.000%		 982,446increase
(New Position)		 Filing
2020-08-06
11:43 am
Purchase		 2020-07-22 13G Acer Therapeutics Inc.
ACER		 HIRSCHMAN ORIN 982,446
11.000%		 430,406increase
(+77.97%)		 Filing
2020-05-19
08:49 am
Purchase		 2020-05-14 13G Acer Therapeutics Inc.
ACER		 HIRSCHMAN ORIN 552,040
11.000%		 552,040increase
(New Position)		 Filing